Emergence of linezolid-resistant coagulase-negative staphylococci in an intensive care unit

References

• Senior K. FDA approves first drug in new class of antibiotics. Lancet. 2010;29:1523.
   Google Scholar
• Meka VG, Gold HS. Antimicrobial resistance to linezolid. Clin Infect Dis. 2004;39:1010–1015.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Hogan PA, Streit JM, et al. Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) Program: report of linezolid activity over 9 years (2004–2012). J Antimicrob Chemother. 2014;69:1582–1588.
   PubMed Web of Science ®Google Scholar
• Flamm RK, Farrell DJ, Mendes RE, et al. LEADER Surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers). Diagn Microbiol Infect Dis. 2012;74:54–61.
   PubMed Web of Science ®Google Scholar
• Matassova NB, Rodnina MV, Endermann R, et al. Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA. 1999;5:939–946.
   PubMed Web of Science ®Google Scholar
• Gu B, Kelesidis T, Tsiodras S, et al. The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother. 2013;68:4–11.
   PubMed Web of Science ®Google Scholar
• Rahim S, Pillai SK, Gold HS, et al. Linezolid-resistant, vancomycin-resistant Enterococcus faecium in patients without prior exposure to linezolid. Clin Infect Dis. 2003;1:146–148.
   Web of Science ®Google Scholar
• Ntokou E, Stathopoulos C, Kristo I, et al. Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2012;67:1819–1823.
   PubMed Web of Science ®Google Scholar
• De Almeida LM, de Araujo MR, Iwasaki MF, et al. Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital. Antimicrob Agents Chemother. 2014;58:2993–2994.
   PubMed Web of Science ®Google Scholar
• Sànchez García M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA. 2010;9:2260–2264.
   Web of Science ®Google Scholar
• Kelly S, Collins J, Maguire M, et al. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother. 2008;61:901–907.
   PubMed Web of Science ®Google Scholar
• Treviño M, Martínez-Lamas L, Romero-Jung PA, et al. Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit. Eur J Clin Microbiol Infect Dis. 2009;28:527–533.
   PubMed Web of Science ®Google Scholar
• Baos E, Candel FJ, Merino P, et al. Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis. 2013;76:325–329.
   PubMed Web of Science ®Google Scholar
• Mulanovich VE, Huband MD, McCurdy SP, et al. Emergence of linezolid-resistant coagulase-negative Staphylococcus in cancer center linked to increased linezolid utilization. J Antimicrob Chemother. 2010;65:2001–2004.
   PubMed Web of Science ®Google Scholar
• Potoski BA, Adams J, Clarke J, et al. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin Infect Dis. 2006;43:165–171.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M07-A9, 8th edn. Clinical and Laboratory Standards Institute; 2012.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 24th informational supplement M100-S24. Clinical and Laboratory Standards Institute; 2014.
   Google Scholar
• Murchan S, Kaufmann ME, Deplano A, et al. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol. 2003;41:1574–1585.
   PubMed Web of Science ®Google Scholar
• Kehrenberg C, Schwarz S. Distribution of florfenicol resistance gene fexA and cfr among chloramphenicol-resistant Staphylococcus isolates. Antimicrob Agents Chemother. 2006;50:1156–1163.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239.
   PubMed Web of Science ®Google Scholar
• Pillai SK, Sakoulas G, Wennersten C, et al. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J Infect Dis. 2002;186:1603–1607.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Deshpande LM, Farrell DJ, et al. Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother. 2010;65:2329–2335.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829.
   PubMed Web of Science ®Google Scholar
• Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45.
   PubMed Web of Science ®Google Scholar
• Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–663.
   PubMed Web of Science ®Google Scholar
• Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530–538.
   PubMedGoogle Scholar
• Bonilla H, Huband MD, Seidel J, et al. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis. 2010;51:796–800.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Deshpande LM, Jones RN. Linezolid updates: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat. 2014;17:1–12.
   PubMed Web of Science ®Google Scholar
• Tewhey R, Gu B, Kelesidis T, et al. Mechanism of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. MBio. 2014;13:1–8.
   Google Scholar
• Diaz L, Kiratisin P, Mendes RE, et al. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother. 2012;56:3917–3122.
   PubMed Web of Science ®Google Scholar
• López-Fabal F, Román Alonso F, Almagro Moltó M, et al. Linezolid resistant coagulase-negative Staphylococcus: phenotypical and genotypical characteristics and sensitivity to antibiotics combinations. Enferm Infecc Microbiol Clin. 2013;31:442–447.
   PubMed Web of Science ®Google Scholar
• Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infections with antimicrobial-resistant Staphylococcus aureus, enterococcus, Gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834–844.
   PubMed Web of Science ®Google Scholar
• Kosowska-Shick K, Julian KG, McGhee PL, et al. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital. Diagn Microbiol Infect Dis. 2010;68:34–39.
   PubMed Web of Science ®Google Scholar
• Álvarez-Lerma F, Palomar M, Olaechea P, et al. Analysis of the treatments used in infections caused by Gram-positive multiresistant cocci in critically ill patients admitted to the ICU. Rev Esp Quimioter. 2012;25:65–73.
   PubMed Web of Science ®Google Scholar
• Ramírez E, Gómez-Gil R, Borobia AM, et al. Improving linezolid use decreases the incidence of resistance among Gram-positive microorganism. Int J Antimicrob Agent. 2013;41:174–178.
   PubMed Web of Science ®Google Scholar